drug
HLD-0915
Phase 2updated 6mo agoby Halda Therapeutics LLC
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- ESMO: J&J exec says RIPTAC readout is ‘best data we’ve ever seen’ for a prostate cancer drugA year after paying over $3 billion for Halda Therapeutics, Johnson & Johnson has unveiled the first data from its shiny new RIPTAC pipeline it believes could sustain its leading role in prostate c…fiercebiotech · 23d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that